Rehovot, Israel

Yaacov Ashani

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Yeda Research and Develpment & Co. Ltd, University of Washington. Active years: 2014-2020.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Yaacov Ashani

Introduction

Yaacov Ashani is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides that address organophosphate exposure. With a total of 2 patents, his work has implications for both medical and environmental safety.

Latest Patents

Ashani's latest patents include groundbreaking innovations. The first patent is for "Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage." This genetically modified polypeptide exhibits at least twice the catalytic efficiency for a V-type nerve agent compared to the standard phosphotriesterase sequence. The second patent is for "Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage." This isolated polypeptide has a catalytic efficiency of k/K ≈ 10-5·10 Mmin for a G-type organophosphate, showcasing its potential in therapeutic applications.

Career Highlights

Throughout his career, Ashani has worked with esteemed organizations such as Yeda Research and Development Company and the University of Washington. His research has focused on developing solutions to mitigate the harmful effects of organophosphate compounds, which are commonly used in pesticides and chemical warfare.

Collaborations

Some of Ashani's notable collaborators include Dan S Tawfik and Moshe Goldsmith. Their combined expertise has contributed to the advancement of research in the field of organophosphate detoxification.

Conclusion

Yaacov Ashani's innovative work in the development of polypeptides for organophosphate exposure demonstrates his commitment to improving public health and safety. His contributions are vital in addressing the challenges posed by toxic substances in our environment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…